Stryker (NYSE:SYK) target price raised to $135.00, reported today … – Breaking Finance News

Yesterday Stryker (NYSE:SYK) traded -0.20% lower at $130.79. The companys 50-day moving average is $124.46 and its 200-day moving average is $117.54. The last stock close price is up 11.27% from the 200-day moving average, compared to the S&P 500 which has increased 0.05% over the same time. 940,446 shares of the stock were exchanged, down from an average trading volume of 1,320,280

Stryker (NYSE:SYK) had its target price raised to $135.00 by RBC Capital in a report released 3/3/2017. The new target price indicates a possible upside of 0.03% based on the company's last stock close price.

Previously on Wednesday January 25, 2017, Canaccord reported about Stryker (NYSE:SYK) raised the target price from $127.00 to $137.00. At the time, this indicated a possible upside of 0.13%.

Stryker has a price-earnings ratio of 30.07 with a one year low of $98.00 and a one year high of $131.36 The companys market cap is currently $0.

In addition to RBC Capital reporting its stock price target, a total of 24 analysts have released a research note on SYK. The one year target is $116.50 with nine analysts rating the company a strong buy, eight equity analysts rating the company a buy, nine equity analysts rating the company a hold, 2 brokers rating the stock a underperform, and finally 1 broker rating the stock a sell.

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company's products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Go here to see the original:

Stryker (NYSE:SYK) target price raised to $135.00, reported today ... - Breaking Finance News